Stocks › CMRX
CMRX
CMRX·USD
—
No end-of-day price on record
CMRX
CMRX
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CMRXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CMRX by members of U.S. Congress · 2 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
James B. RenacciHouse · R · OH |
CMRXCMRX · Stock |
Sale $1,001 - $15,000 |
Dec 21, 2015 | Dec 9, 2015 | Filing ↗ |
James B. RenacciHouse · R · OH |
CMRXCMRX · Stock |
Purchase $15,001 - $50,000 |
Feb 10, 2015 | Jan 28, 2015 | Filing ↗ |
Whale Activity
Position changes in CMRX reported for 2025-09-30 by 1 institutional filer
- Increased0
- New0
- Held0
- Decreased0
- Closed1
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| Koshinski Asset Management, Inc. | 0 | $0 | closed |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CMRX insiders, by quarter · Form 4
Recent Insider Transactions
407 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Sherman Michael A.Chief Executive Officer · Director | Disposition to issuer | −233.4K | $8.55 | $2.0M | Apr 21, 2025 | Form 4 ↗ |
| Sherman Michael A.Chief Executive Officer · Director | Disposition to issuer | −103.0K | $8.55 | $881K | Apr 21, 2025 | Form 4 ↗ |
| Sherman Michael A.Chief Executive Officer · Director | Disposition to issuer | −87.0K | $8.55 | $744K | Apr 21, 2025 | Form 4 ↗ |
| Riga Thomas JCOO and CCO | Disposition to issuer | −60.8K | $8.55 | $520K | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −207.5K | $8.55 | $1.8M | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −531.9K | $8.55 | $4.5M | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −2.8M | $8.55 | $23.7M | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −60.0K | $8.55 | $513K | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −40.0K | $8.55 | $342K | Apr 21, 2025 | Form 4 ↗ |
| Meyer Robert J.Director | Disposition to issuer | −35.1K | $8.55 | $301K | Apr 21, 2025 | Form 4 ↗ |
| Melemed Allen S.CHIEF MEDICAL OFFICER | Disposition to issuer | −173.9K | $8.55 | $1.5M | Apr 21, 2025 | Form 4 ↗ |
| LaSpaluto MichelleCHIEF FINANCIAL OFFICER | Disposition to issuer | −181.5K | $8.55 | $1.6M | Apr 21, 2025 | Form 4 ↗ |
| Jakeman DavidVP OF FINANCE AND ACCOUNTING | Disposition to issuer | −156.2K | $8.55 | $1.3M | Apr 21, 2025 | Form 4 ↗ |
| DEMSKI MARTHA JDirector | Disposition to issuer | −72.1K | $8.55 | $616K | Apr 21, 2025 | Form 4 ↗ |
| Andriole Michael T.PRESIDENT AND CEO · Director | Disposition to issuer | −630.8K | $8.55 | $5.4M | Apr 21, 2025 | Form 4 ↗ |
| Alrutz Michael AlbertSVP AND GENERAL COUNSEL | Disposition to issuer | −216.7K | $8.55 | $1.9M | Apr 21, 2025 | Form 4 ↗ |
| Melemed Allen S.CHIEF MEDICAL OFFICER | Sale | −3,065 | $4.50 | $14K | Feb 13, 2025 | Form 4 ↗ |
| Andriole Michael T.PRESIDENT AND CEO · Director | Sale | −7,370 | $4.52 | $33K | Feb 13, 2025 | Form 4 ↗ |
| Alrutz Michael AlbertSVP AND GENERAL COUNSEL | Sale | −1,600 | $4.52 | $7K | Feb 13, 2025 | Form 4 ↗ |
| Jakeman DavidVP OF FINANCE AND ACCOUNTING | Sale | −300 | $4.53 | $1K | Feb 13, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CMRX · SEC Form N-PORT
No mutual fund or ETF has reported CMRX in an N-PORT filing in the last seven months.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming CMRX as client
No lobbying filings found naming CMRX as the client.
Government Contracts
Federal awards to CMRX · USAspending
No federal contract awards found for CMRX.
U.S. Patents
Recent USPTO applications naming CMRX
No USPTO patent applications found for CMRX.
Annual Financials
From CMRX's 10-K filings · XBRL
CMRX is not in SEC's company list, so there are no XBRL filings to show.
Stock Splits
Every split and reverse split in the price history
No price history on record for CMRX.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About CMRX
From SEC EDGAR company records
No company profile on record.

